Thus, PTP1B has been identified as a target for research and development of new drugs for the treatment of type 2 diabetes, and PTP1B inhibitors are potential lead compounds for such new drugs (Teng et al., 2011). The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.